Aprea Therapeutics Files For U.S. IPO [Seeking Alpha]
Janus Henderson Group plc Ordinary Shares (JHG)
Last janus henderson group plc ordinary shares earnings: 4/30 04:00 am
Check Earnings Report
US:NYSE Investor Relations:
snl.com/irw/corporateprofile/4147331
Company Research
Source: Seeking Alpha
Aprea Therapeutics Files For U.S. IPO Summary Aprea Therapeutics has filed to raise $86 million in an IPO, although the final figure may differ. The company is advancing treatment programs for MDS and AML cancers. APRE expects topline readout for its lead program in 2H 2020. Quick Take Aprea Therapeutics ( S-1 registration statement The firm is developing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. APRE is in Phase 3 trials for its lead candidate with an expected next potential major milestone in the second half of 2020. I’ll provide an update when we learn more IPO details from management. Company & Technology Boston, Massachusetts-based Aprea was founded in 2003 with a focus on developing cancer therapeutics that activate the reactive mutant p53 tumor suppressor protein, expressed by the TP53 gene which management claims is the most commonly mutated gene in cancer. Management is headed by President, CEO and Director Christian S. Schade JNJ Aprea’s lead d
Show less
Read more
Impact Snapshot
Event Time:
JHG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JHG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JHG alerts
High impacting Janus Henderson Group plc Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JHG
News
- $7 billion fund manager touts three blue-chip stocks [Yahoo! Finance]Yahoo! Finance
- The great dividend payout: Investors raked in a record $1.66 trillion last year—and 2024 is shaping up to be another blowout [Yahoo! Finance]Yahoo! Finance
- Castings P.L.C. (LON:CGS) is a favorite amongst institutional investors who own 61% [Yahoo! Finance]Yahoo! Finance
- This Top Fund Likes Microsoft, Visa, AT&T, and Other Dividend Growth Plays [Yahoo! Finance]Yahoo! Finance
- Stock market today: US futures steady with investors on data watch [Yahoo! Finance]Yahoo! Finance
JHG
Earnings
- 2/1/24 - Beat
JHG
Sec Filings
- 3/22/24 - Form DEFA14A
- 3/22/24 - Form DEF
- 3/22/24 - Form ARS
- JHG's page on the SEC website